- Home
- XLO vs GNS Comparison
XLO vs GNS Comparison
Compare XLO & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XLO | GNS |
|---|---|---|
| Founded | 2016 | 2002 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.8M | 43.9M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | XLO | GNS |
|---|---|---|
| Price | $0.57 | $0.42 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | 572.5K | ★ 934.3K |
| Earning Date | 03-10-2026 | 09-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $31,804,000.00 | $5,749,894.00 |
| Revenue This Year | $626.78 | $82.78 |
| Revenue Next Year | $79.08 | $85.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 588.40 | N/A |
| 52 Week Low | $0.50 | $0.21 |
| 52 Week High | $1.70 | $1.92 |
Technical Indicators
Market Signals| Indicator | XLO | GNS |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 30.85 |
| Support Level | $0.50 | $0.36 |
| Resistance Level | $0.61 | $0.50 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 55.80 | 15.21 |
Price Performance
Historical ComparisonAbout XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.